Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is one of the more common experiences people report when they start Wegovy or increase their dose — and it is, in most cases, a sign your body is adjusting, not a reason to stop. It tends to appear in the first week or two of a new dose level and settles for the majority of people as their system adapts to semaglutide. That said, tiredness that is severe, persistent, or arrives alongside other symptoms deserves a closer look. Wegovy is a prescription-only medicine, and any concerns about how it is affecting you should be discussed with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks goes something like this: "I've been exhausted since starting Wegovy, does that mean it's not right for me?" The short answer is no. Fatigue during the early weeks of semaglutide treatment is common enough that it appears on the NHS semaglutide medicines page as a recognised side effect, alongside nausea, headache, and dizziness. Feeling tired does not signal that treatment is failing or that your body is rejecting the medicine.
The misconception stems from a reasonable but incomplete reading of the situation. People assume that a medicine suppressing appetite should make them feel lighter and more energetic straight away. In reality, the adjustment phase works the other way. Your body is recalibrating hunger hormones, gastric emptying is slowing, and if you are eating less (which is the point), your overall energy intake is lower than before. That combination can leave you feeling flat, particularly mid-afternoon or after activity. It is a transient effect for most people, not a permanent new baseline.
There is a second layer to this, too. If nausea or vomiting is reducing what you manage to eat and drink, mild dehydration and lower carbohydrate intake can amplify tiredness considerably. Staying hydrated and maintaining adequate protein intake makes a real practical difference during this phase.
Wegovy follows a step-by-step dose schedule, and the adjustment process tends to replay, to a lesser degree, each time the dose increases. Many people find they felt fine on their previous dose and are surprised to feel fatigued again after moving up. This is expected rather than alarming. The underlying mechanisms are the same: a higher dose of semaglutide slows gastric emptying more, may suppress appetite further, and can intensify the early gastrointestinal side effects that indirectly drive tiredness.
For most people the pattern resolves within one to two weeks of each new dose level. Practically speaking, it helps to plan around it. Lighter activity rather than intense exercise during the first week of a new dose, prioritising sleep, and eating nutrient-dense small meals rather than skipping them altogether can all smooth the transition. If you are struggling with sickness alongside the fatigue, the guide to managing nausea on Wegovy covers practical approaches that prescribers commonly suggest.
One thing worth noting: people who are also taking other medicines that can cause drowsiness should flag the combination with their prescriber. Semaglutide can affect the absorption timing of some oral medicines because it slows how quickly the stomach empties. Your prescribing team is best placed to assess whether anything in your existing regimen is compounding the fatigue.
Most fatigue on semaglutide resolves on its own. But there are patterns that should prompt a call to your prescriber rather than a wait-and-see approach. The full side-effect overview for Wegovy sets out the warning signs in more detail, but the key ones in the context of tiredness include:
Severe, persistent fatigue that does not ease after two to three weeks on a stable dose. Tiredness paired with stomach pain that reaches into your back, this combination is flagged in MHRA safety guidance as a possible sign of pancreatitis, which requires urgent medical attention. Low mood, low motivation, or feelings of hopelessness alongside physical fatigue, because mental health changes can sometimes emerge during treatment and your prescriber needs to know. Dizziness or faintness, which can point to dehydration or low blood pressure worth checking. Significant vomiting that is stopping you from keeping food or fluids down, this is covered in more depth in the guide to vomiting on semaglutide.
If any of these apply to you, contact your prescribing team. At nume, clinical support is available seven days a week. Alternatively, if you feel unwell enough to need urgent help, NHS 111 is always available.
The broader pattern of feeling unwell on semaglutide is well documented in the clinical literature and does not, on its own, mean treatment needs to stop. But the prescriber (not the patient) is the right person to make that call, based on the full picture of how you are responding.
There is no single fix, but the things that make the most difference in practice are straightforward. Drink enough water, dehydration from reduced food and fluid intake is underestimated as a fatigue driver on GLP-1 treatment. Eat protein at every meal, even small ones; protein supports energy levels and helps protect muscle mass during weight loss. Prioritise sleep, especially in the first fortnight of a new dose. Gentle movement (a walk, light stretching) tends to help more than complete rest, but this is not the time to push intensity.
If you are thinking about the financial side of ongoing treatment, the Wegovy cost comparison page sets out what private treatment typically includes and why the components of that price matter. Continuity of clinical support (including being able to raise concerns like fatigue easily) is part of what you are paying for with a regulated service.
For anyone who has not yet started treatment and is weighing up their options, our free consultation is reviewed the same day by a GPhC-registered prescriber. They can talk through your specific circumstances, including anything in your history that might affect how you tolerate semaglutide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.